Status:
UNKNOWN
Fibrinolytic Deficit in Patients With Acute PE
Lead Sponsor:
Loyola University
Collaborating Sponsors:
Boston Scientific Corporation
Conditions:
Acute Pulmonary Embolism
Fibrinolytic Deficit
Eligibility:
All Genders
18-90 years
Brief Summary
Fibrinolysis is the body's process that prevents blood clots. The investigators hypothesize that patients presenting with acute pulmonary embolism (PE) or blood clots in the lungs differ in their fibr...
Detailed Description
Patients (n=100) identified by the Pulmonary Embolism Response Team (PERT) suffering from a PE will be identified by the PI. Blood plasma samples from these patients which have been drawn for routine ...
Eligibility Criteria
Inclusion
- Patients age 18 - 90 years
- Patients suffering an acute PE
- Blood collected for clinical evaluation of PE
Exclusion
- Blood not collected or not sufficient quantity/quality
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04480892
Start Date
August 1 2020
End Date
December 1 2024
Last Update
July 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Loyola University Medical Center
Maywood, Illinois, United States, 60153